Connect with us
European Gaming Congress 2024

Artificial Intelligence

Global Histology and Cytology Market to Surpass US$ 39,073.7 Million by 2028, Says Coherent Market Insights (CMI)

Published

on

SEATTLE, Aug. 20, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global histology and cytology market is estimated to be valued at US$ 16,253.0 million in 2021 and is expected to exhibit a CAGR of 13.35% over the forecast period (2021-2028).

Key Trends and Analysis of the Global Histology and Cytology Market:

Key trends in the market include the increasing prevalence of cancer, increasing approval of novel products, and increasing mergers, collaborations, partnerships, and acquisitions among key players. These key trends are expected to aid in growth of histology and cytology market.

For instance, according to the American Cancer Society, it is estimated that in 2021 around 1,898,160 new cases of cancer and 608,570 cancer deaths would be recorded in the U.S. Moreover, the American Cancer Society estimates that most of the cancer cases would be accounted by digestive system related cancer such as colon cancer, pancreatic cancer, esophagus cancer, stomach cancer, and others.

Furthermore, increasing launches and approvals of novel products is expected to drive the market growth over the forecast period. For instance, in November 2020, Hologic, Inc., a U.S.-based medical device company received CE mark for its new Genius Digital Diagnostics System to be distributed in Europe. Genius Digital Diagnostics System uses an artificial intelligence (AI) algorithm to offer better digital imaging of cancer cells as well as pre-cancerous lesions in cases of cervical cancer in women.

Advertisement
Stake.com

Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4591

Furthermore, key players operating in the global histology and cytology market are focusing on adoption of inorganic growth strategies such as acquisitions and collaborations, in order to expand their market presence in the global market. For instance, in June 2020, Biocare Medical LLC, a U.S.-based medical diagnostic solution provider collaborated with Bethyl Laboratories, Inc., a Texas-based antibody products provider to develop a cost-effective antibodies for cancer diagnostics and expand immunohistochemistry product portfolio.

Key Market Takeaways:

The global histology and cytology market is expected to exhibit a CAGR of 13.35% over the forecast period, owing to rising product launches and approvals. For instance, in July 2020, Becton, Dickinson and Company, a U.S.-based medical technology company received approval from the U.S. Food and Drug Administration (FDA) for new version of BD Onclarity HPV Assay, which is indicated to be used for detection of Human Papillomavirus based on histology of cervical samples.

Among examination type, cytology segment is expected to account for largest market share over the forecast period, owing to market players focusing on launching new products. For instance, in March 2020, ELITechGroup, a France-based diagnostic solution provider launched its new Aerospray Cytology Slide Stainer/Cytocentrifuge, which helps in complete automation of cytology slide preparation. Samples such as urine, mucus, body cavity fluids, cerebrospinal fluid, and others can be stained using Aerospray Cytology Slide Stainer/Cytocentrifuge and be further utilized in cytology studies.

Advertisement
Stake.com

Competitive Landscape:

Key players operating in the global histology and cytology market include Abbott, Hologic Inc., Becton, Dickinson and Company, Southwest Precision Instruments, LLC, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher, Life Technologies Corporation, Merck KGaA, Koninklijke Philips N.V., Perkin Elmer, and Trivitron Healthcare.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4591

Market Segmentation:

  • Global Histology and Cytology Market, By Product Type:
    • Instruments and Analysis Software System
    • Consumable and Reagents
  • Global Histology and Cytology Market, By Examination Type:
    • Histology
    • Cytology
      • Breast Cancer
      • Cervical Cancer
      • Others (Others include Oral Cancer, Leukemia, Infectious Diseases, and Inflammatory Diseases)
  • Global Histology and Cytology Market, By Test Type:
    • Microscopy Tests
      • CytogenicTests
      • Polymerase Chain Reaction
    • Molecular Genetics Tests
    • Flow Cytomtery
  • Global Histology and Cytology Market, By End User:
    • Hospitals and Clinics
    • Academic and Research Institutes
    • Others
  • Global Histology and Cytology Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

Blood and Blood Components Market, by Product Type (Whole Blood and Blood Components (Red Blood Cells, White Blood Cells, Platelets, and Plasma)), by Application (Anemia, Trauma and Surgery, Cancer Treatment, Bleeding Disorders, and Others (Others include rare blood diseases)), by End User (Hospitals, Ambulatory Surgical Centers, Blood and Blood Component Bank, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Advertisement
Stake.com

Read more: https://www.globenewswire.com/en/news-release/2021/08/16/2281124/0/en/Global-Blood-and-Blood-Components-Market-to-Surpass-US-56-242-3-Million-by-2028-Says-Coherent-Market-Insights-CMI.html

Gene Panel Market, by Technique (Amplicon-Based and Hybridization-Based), by Design (Predesigned Gene Panels and Customized Gene Panels), by Application (Pharmacogenetics, Diagnosis of Congenital Disorders, Cancer Risk Assessment, and Others), by End User (Research and Academic Institutes, Hospital and Diagnostic Laboratories, and Biotechnology and Pharmaceutical Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Read more: https://www.globenewswire.com/en/news-release/2021/08/02/2272889/0/en/Global-Gene-Panel-Market-to-Surpass-US-29-975-8-Million-by-2028-Says-Coherent-Market-Insights-CMI.html

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Advertisement
Stake.com

Follow Us: LinkedInTwitter


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

CRISIL wins Model Validation Tools and Accelerators category award, other recognitions from Chartis

Published

on

crisil-wins-model-validation-tools-and-accelerators-category-award,-other-recognitions-from-chartis

Recognized among top 50 financial services firms for analytics and risk tech
MUMBAI, India, June 18, 2024 /PRNewswire/ — CRISIL, a global provider of advanced analytics and risk management solutions, has won the Solution Category award for Model Validation Tools and Accelerators as part of the latest Chartis STORM 2024 report.

Published by Chartis Research, the leading provider of research and analysis on the global market for risk technology, STORM 2024 is an annual report on quantitative technologies and the computational infrastructure supporting it.
Following an extensive evaluation process, which included a risk technology survey, product demo, customer reference checks, and third-party sources of information, CRISIL won the following recognitions:
Solution category award for Model Validation Tools and AcceleratorsRanked Top 25 (#24) in QuantTech50 2024 rankingsRanked Top 25 (#24) in BuySideRisk50 2024 rankingsRanked Top 50 (#38) in RetailFinanceAnalytics50 2024 rankingsThe recognitions reflect the unparalleled value CRISIL brings to its clients through deep domain expertise, specialized analytical and technical knowledge and our global perspective.
Says Jan Larsen, President and Head, CRISIL Global Research & Risk Solutions, “CRISIL is honored by the recognition across multiple STORM50 award categories this year, including being named first place for Model Validation Tools and Accelerators. This is a great testament to the contributions of our team in giving clients and their regulators confidence in the models they use for making critical decisions.”
The core tenets of CRISIL’s value proposition include expertise across asset classes and risk stripes, analytical excellence and regulatory experience, tailored solutions focused on client delight, continuous improvement and technological innovation. 
Says Ashish Vora, President, CRISIL Market Intelligence and Analytics, “This prestigious recognition underscores the global acceptance of our risk management solutions and highlights our unwavering commitment to excellence in the risk technology space. Our Credit+ technology solutions have been instrumental in offering AI-enabled advanced analytics and driving efficiency, and we are particularly proud of the exceptional client feedback we have received for these solutions. We are constantly exploring new ways to enhance customer value and are investing in cutting-edge technology and domain expertise to maintain our position at the forefront of the industry.”
Notable examples of CRISIL’s platforms that help demonstrate this value proposition include: 
Model Infinity: A leading platform for model inventory management and model risk management. This innovative platform empowers our client to centralize all model activities, eliminates manual processes and operational risk, and provides a full audit trail of approvals for modeling assumptions and updates. Scenario Expansion Manager (SEM): A platform for clients to expand, analyze and track all regulatory and internal scenarios used for stress testing. As a centralized repository of scenarios, SEM allows institutions to eliminate redundant internal work and even provide clients the ability to share internal scenarios with one another. Credit+ ICON: The platform enables credit decision-making through its extensive financial spreading and front-end based credit risk scorecard hosting capabilities. Powered by deep domain expertise, AI-driven analytics and extensive configurability, it serves 40+ global clients across 15 countries.Credit+ Early Warning Signals: The AI-powered solution provides banks with actionable insights to monitor their credit quality, lower loan-loss contingencies and track corrective action plan.About CRISIL Market Intelligence & Analytics
About Global Research & Risk Solutions
About CRISIL Limited
Connect with us: LINKEDIN | TWITTER | YOUTUBE | FACEBOOK 
CRISIL PRIVACY
Disclaimer
This press release is transmitted to you for the sole purpose of dissemination through your newspaper/ magazine/ agency. The press release may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution of its press releases for consideration or otherwise through any media including websites, portals, etc.
CRISIL has taken due care and caution in preparing this press release. Information has been obtained by CRISIL from sources which it considers reliable. However, CRISIL does not guarantee the accuracy, adequacy or completeness of information on which this press release is based and is not responsible for any errors or omissions or for the results obtained from the use of this press release. CRISIL, especially states that it has no financial liability whatsoever to the subscribers/ users/ transmitters/ distributors of this press release.
Logo – https://mma.prnewswire.com/media/2211784/4276223/CRISIL_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/crisil-wins-model-validation-tools-and-accelerators-category-award-other-recognitions-from-chartis-302175882.html

Continue Reading

Artificial Intelligence

Enfuse Group acquires Truly Intelligent Business IP to further develop data capability

Published

on

enfuse-group-acquires-truly-intelligent-business-ip-to-further-develop-data-capability

LONDON, June 18, 2024 /PRNewswire/ — Enfuse Group, a multi award-winning transformation consultancy, is delighted to announce the acquisition of the intellectual property from data consultancy Truly Intelligent Business (TIB).

This acquisition evolves the existing partnership between Enfuse Group and TIB, where they’ve worked together to simplify and accelerate data value for some of the world’s most recognisable brands, including The Financial Times and McDonald’s UK&I. This acquisition now fully embeds all of TIB’s powerful data value accelerators within Enfuse Group’s wider capabilities, enabling Enfuse Group to help even more organisations to be more data-driven, and less data-busy! This acquisition also sees Phil Husbands, Founder & Director of TIB move to Enfuse Group to spearhead the enhanced Enfuse Data & AI capability.
Enfuse Group’s expanded portfolio now features cutting-edge solutions that simplify data complexity, reduce costs, and maximise data return on investment. This includes 4dDX – A strategic data capability framework that quickly and easily creates powerful data strategies and ADEA (Accelerated Data Enablement Architecture) that simplifies and accelerates organisations’ ability to be more data-driven and less ‘data-busy’. Additionally, Enfuse Group has acquired a number of data accelerators that enable organisations to rapidly improve their data visibility, insights, governance, and operating models.
Josh Rubin, Chief Growth Officer at Enfuse Group commented: “This acquisition marks a significant milestone in our growth journey and the investment is a signal of intent on how we are further building our capabilities in the data, AI, and analytics space. We know from speaking to our clients how much they are struggling with the rapid growth of the data in their organisations and the need to get this under control to derive real business value. We are very excited to build on the great tools and approaches that TIB have been so successful with to-date and help further scale these to help a broader set of clients”.
Phil Husbands, Director at TIB commented “I’m delighted that our partnership with Enfuse Group has evolved to this stage, where TIB’s data accelerators can now reach more businesses and organisations, and our determined focus on ‘data-driven not data-busy’ will be boosted by the talent and expertise of the whole team at Enfuse Group”.
About Enfuse Group
Enfuse Group is a UK headquartered transformation consultancy who work with clients across both private and public sectors shaping and delivering their biggest transformations. Enfuse Group were recognised in the Financial Times Leading Consultancies across three categories, as well as being named Best New Consultancy in 2023 by the Management Consultancies Association (MCA).www.enfusegroup.com
To learn more about these Data Accelerators or for any enquiries, please contact [email protected]
 

View original content:https://www.prnewswire.co.uk/news-releases/enfuse-group-acquires-truly-intelligent-business-ip-to-further-develop-data-capability-302175816.html

Continue Reading

Artificial Intelligence

SURFLINE AND ENDLESS SURF PARTNER TO ADVANCE THE WAVEPOOL MOVEMENT

Published

on

surfline-and-endless-surf-partner-to-advance-the-wavepool-movement

New partnership combines Surfline’s industry-leading camera and relive technology with Endless Surf’s world-class waves.
HUNTINGTON BEACH, Calif., June 18, 2024 /PRNewswire/ — Surfline and Endless Surf announced a new strategic partnership, which will deliver transformational benefits for surfer progression and unlock significant revenue opportunities for wave parks globally.

Surfline, the leading arbiter of good waves globally, has identified Endless Surf as a future standard bearer in wave technology and is designating participating surf parks powered by Endless Surf as Surfline ‘Premier Parks’. Premier Parks will have access to Surfline’s industry-leading camera infrastructure which will enable them to provide live streaming and relive video experiences to their customers. Premier Parks will benefit not only from Surfline’s technology, but also Surfline’s reach, powerful marketing platform and global audience of millions of surfers, allowing Premier Parks to drive bookings and find new customers.
Surfline is also on the eve of launching their AI-based camera technology, which will further establish them as the place where every surfer’s life lives. This experience will launch at key spots in ocean environments during summer 2024 and select wave pools shortly after. Endless Surf parks around the world will be able to leverage this same technology to offer customers video clips during and after visits to participating parks.
“We are thrilled to partner with Endless Surf,” said Ross Garrett, CEO of Surfline. “By pairing our camera technology with Endless Surf’s next-generation wave technology, we will create incredible new experiences and accelerate innovation for pool and ocean surfers.”
Paul Chutter, President of Endless Surf, notes how natural of a fit this partnership is, saying, “This partnership is strategically significant for both of us. The Premier Parks offering enhances the Endless Surf experience for both our customers building surf venues and the end-user that will surf, and now relive, our world-class waves. We’re proud to partner with a likeminded company to continue shaping the future of surfing beyond the ocean.”
Both companies are excited to build on their histories of innovation and delivering authentic value to surfers. This new alliance will further boost the surf park business model, as it unlocks significant revenue opportunities for participating venues. Stay tuned for more as Surfline launches its AI-based technology this summer, and as over a dozen Endless Surf projects in development progress globally.
To learn more about these companies visit Surfline.com and EndlessSurf.com
Photo – https://mma.prnewswire.com/media/2441254/ES_Surfline_Graphic_1_2__3.jpg

View original content:https://www.prnewswire.co.uk/news-releases/surfline-and-endless-surf-partner-to-advance-the-wavepool-movement-302175129.html

Continue Reading
Advertisement
Stake.com
Advertisement

Latest News

Trending